60 mg/10 mL 3341 Hypercalcaemia of malignancy refractory to anti-neoplastic therapy N/A injection, 1 x 10 mL vial 90 mg 3341 Hypercalcaemia of malignancy refractory to anti-neoplastic therapy N/A 3342 Multiple myeloma 3343 Bone metastases from breast cancer 4 vials powder 3341 Treatment of hypercalcaemia of malignancy refractory to anti-neoplastic therapy N/A 15 mg + 4 ampoules solvent 5 ml 2 vials powder 3256 disease of bone N/A 30 mg + 2 ampoules solvent 10 ml Concentrated N/R Treatment of hypercalcaemia of malignancy refractory to anti-neoplastic therapy N/A injection 15 3256 Symptomatic Paget disease of bone mg in 5 mL Concentrated N/R Treatment of hypercalcaemia of malignancy refractory to anti-neoplastic therapy N/A injection 30 3256 Symptomatic Paget disease of bone mg in 10 mL Concentrated N/R Treatment of hypercalcaemia of malignancy refractory to anti-neoplastic therapy N/A injection 60 3256 Symptomatic Paget disease of bone mg in 10 mL Concentrated N/R Treatment of hypercalcaemia of malignancy refractory to anti-neoplastic therapy N/A injection 90 mg in 10 mL 90 mg N/R Hypercalcaemia of malignancy refractory to anti-neoplastic therapy N/A injection [1 x Multiple myeloma 90 mg vial] (&) Bone metastases from breast cancer inert substance diluent [1 x 10 mL ampoule], 1 pack
60 mg/10 mL injection, 1 x 10 mL vial 3341 Hypercalcaemia of malignancy refractory to anti-neoplastic therapy N/A 90 mg 3341 Hypercalcaemia of malignancy refractory to anti-neoplastic therapy N/A 3342 Multiple myeloma 3343 Bone metastases from breast cancer 4 vials powder 15 mg + 4 ampoules solvent 5 ml 3341 Treatment of hypercalcaemia of malignancy refractory to anti-neoplastic therapy N/A 2 vials powder 30 mg + 2 ampoules solvent 10 ml 3256 disease of bone N/A Concentrated injection 15 mg in 5 mL N/R 3256 Treatment of hypercalcaemia of malignancy refractory to anti-neoplastic therapy Symptomatic Paget disease of bone N/A Concentrated injection 30 mg in 10 mL N/R 3256 Treatment of hypercalcaemia of malignancy refractory to anti-neoplastic therapy Symptomatic Paget disease of bone N/A Concentrated injection 60 mg in 10 mL N/R 3256 Treatment of hypercalcaemia of malignancy refractory to anti-neoplastic therapy Symptomatic Paget disease of bone N/A Concentrated injection 90 mg in 10 mL N/R Treatment of hypercalcaemia of malignancy refractory to anti-neoplastic therapy N/A 90 mg injection [1 x 90 mg vial] (&) inert substance diluent [1 x 10 mL ampoule], 1 pack N/R Hypercalcaemia of malignancy refractory to anti-neoplastic therapy Multiple myeloma Bone metastases from breast cancer N/A
App1317-FinalDAP-accessible.docx